Eating Disorders The hyperfocus on GLP1As weight loss effects could accentuate weightcentric culture and increase risk of eating disorders like anorexia nervosa and bulimia nervosa [1]
With NAD, patients typically notice changes quickly
For randomized controlled trials (RCTs), the Cochrane Risk of Bias 2.0 (RoB 2.0) tool was applied, evaluating bias arising from the randomization process, deviations from intended interventions, missing outcome data, measurement of outcomes, and selection of the reported result
Does morning or evening semaglutide injection affect sleep differently
As an antioxidant, CoQ 10 has demonstrated to be potentially used as a treatment in diseases which have oxidative stress as a hallmark in their aetiologies
Any change to a GLP-1 medication schedule, including tapering, requires guidance from the prescribing provider